[Vasoactive treatment in digestive hemorrhage caused by rupture of esophageal varices].
Hadengue
A
A
Unité de Recherches de Physiopathologie Hépatique (INSERM U 24) et Service d'Hépatologie, Hôpital Beaujon, Clichy.
D004932:Esophageal and Gastric Varices / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006439:Hemodynamics / Q000187:drug effects; D006489:Hemostatic Techniques; D006801:Humans; D012422:Rupture, Spontaneous; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
Traitements vaso-actifs au cours des hémorragies digestives par rupture de varices oesophagiennes.